These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
545 related items for PubMed ID: 26163919
1. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer. Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A. Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919 [Abstract] [Full Text] [Related]
8. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients? Simsek FS, Comak A, Asik M, Kuslu D, Balci TA, Ulutas H, Koroglu R, Kekilli E, Akatli A, Elmali F, Yalcin NC, Akyol H. Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121 [Abstract] [Full Text] [Related]
10. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT. Wang Y, Ma S, Dong M, Yao Y, Liu K, Zhou J. BMC Pulm Med; 2015 Mar 08; 15():20. PubMed ID: 25880540 [Abstract] [Full Text] [Related]
12. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT. Park B, Kim HK, Choi YS, Kim J, Zo JI, Choi JY, Shim YM. Korean J Radiol; 2015 Mar 08; 16(4):929-35. PubMed ID: 26175595 [Abstract] [Full Text] [Related]
13. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S. Eur J Cardiothorac Surg; 2013 Jul 08; 44(1):83-7. PubMed ID: 23233074 [Abstract] [Full Text] [Related]
14. Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT. Futamura M, Asano T, Kobayashi K, Morimitsu K, Nawa M, Kanematsu M, Morikawa A, Mori R, Yoshida K. World J Surg Oncol; 2015 Feb 14; 13():49. PubMed ID: 25885028 [Abstract] [Full Text] [Related]
15. The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer. Liao X, Liu M, Li S, Huang W, Guo C, Liu J, Xiong Y, Zhang J, Fan Y, Wang R. BMC Med Imaging; 2023 Apr 05; 23(1):49. PubMed ID: 37020286 [Abstract] [Full Text] [Related]
18. The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients. Koksal D, Demirag F, Bayiz H, Ozmen O, Tatci E, Berktas B, Aydoğdu K, Yekeler E. J Cardiothorac Surg; 2013 Apr 04; 8():63. PubMed ID: 23557204 [Abstract] [Full Text] [Related]
19. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan. Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N. Ann Nucl Med; 2009 Aug 04; 23(6):523-31. PubMed ID: 19444550 [Abstract] [Full Text] [Related]
20. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer. Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T. Clin Radiol; 2019 Oct 04; 74(10):818.e17-818.e23. PubMed ID: 31420186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]